fiercehealthcare.com
The Food and Drug Administration (FDA) will remove broad “black box” warning labels from hormone replacement therapy (HRT) for menopause. | The action, announced Monday, follows a comprehensive review of scientific literature by an expert panel at the agency in July, as well as a public comment period, officials said. Pharmas are expected to update and reprint their product labeling to remove references to risks of cardiovascular disease, breast cancer and probable dementia.
about 1 month ago